Boehringer Ingelheim becomes member of IPC

Boehringer Ingelheim is pleased to announce that the company has joined the International Poultry Council (IPC) as its new Associate Member. IPC is a member-driven organization comprised of national sector associations, poultry businesses and other key industry stakeholders. IPC members represent more than 88 percent of the world poultry meat production and 95 percent of the global poultry meat trade.

IPC commits to:

• bring together poultry industry stakeholders from across the globe to build relationships and gain a better understanding of shared challenges;
• represent the whole value chain from farm to fork, from genetics to consumption;
• create a pre-competitive agenda that leverages the strengths and resources of national organizations;
• speak as a unified and harmonized voice of the poultry sector.

At Boehringer Ingelheim, we are strongly committed to the long-term success of the poultry industry globally and this membership will enable us to participate, even more strongly, in advocating for the importance of and trust in poultry products around the world. With our products and services as well as our work in this critical sector, we aim to continue to contribute to feeding the world with safe, affordable, abundant and sustainable high quality poultry meat and eggs.

“We are very proud to be part of IPC which brings together poultry industry stakeholders and represents a unified and harmonized voice of the poultry sector. Its mission fits well with our commitment to shape the future of poultry well-being and health through disease prevention,” shares Jérôme Baudon, Global Head of Poultry at Boehringer Ingelheim Animal Health.

“IPC is delighted to welcome Boehringer Ingelheim Animal Health, a leader in poultry health, with a global footprint around the world. We are convinced that the company will be a strong voice of the poultry industry on the main topic related to the poultry value chain and will contribute to a fact and science-based approach to public policy and international standards, impacting the poultry sector on food safety, sustainability, animal health and animal welfare. IPC family is getting bigger, we bring together poultry leaders from around the world!” says IPC President Robin Horel. 

About IPC:

Founded on  October 7, 2005 in the city of Cologne, Germany, the International Poultry Council (IPC) is the global poultry meat producers Association. IPC’s mission is to strengthen communications between countries, to develop and implement policy for international organizations affecting the world’s poultry industry, and to promote a common understanding of and confidence in poultry products in the world.
The IPC currently has 31 Country Members and more than 53 Associate Members, representing 88 percent of the global poultry meat production and almost 95 percent of the global poultry meat trade. International Organizations such as OIE, FAO and Codex Alimentarius Commission officially recognize IPC as the global Association representing the poultry sector. https://internationalpoultrycouncil.org/ 

Boehringer Ingelheim Animal Health
The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. Across the globe, our 10,000 employees are dedicated to delivering value through innovation, thus enhancing the well-being of both.

Respect for animals, humans and the environment is at the heart of what we do. We develop solutions and provide services to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society-threatening diseases.

Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with net sales of 4 billion euros in 2019 and presence in more than 150 countries. 

For more information visit: www.boehringer-ingelheim.com/animal-health/overview.

Boehringer Ingelheim
Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim is independent and family-owned. We have the freedom to pursue our long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good.

As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of 19 billion euros. Our significant investment of almost 3.5 billion euros in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life. 

We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.

More information about Boehringer Ingelheim can be found at www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.

Intended audiences:

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.